JCR Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
JCR Pharmaceuticals has a total shareholder equity of ¥55.9B and total debt of ¥23.3B, which brings its debt-to-equity ratio to 41.6%. Its total assets and total liabilities are ¥102.8B and ¥46.8B respectively. JCR Pharmaceuticals's EBIT is ¥7.8B making its interest coverage ratio -178. It has cash and short-term investments of ¥18.3B.
Key information
41.6%
Debt to equity ratio
JP¥23.30b
Debt
Interest coverage ratio | -178x |
Cash | JP¥18.30b |
Equity | JP¥55.95b |
Total liabilities | JP¥46.83b |
Total assets | JP¥102.77b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 4552's short term assets (¥57.5B) exceed its short term liabilities (¥31.9B).
Long Term Liabilities: 4552's short term assets (¥57.5B) exceed its long term liabilities (¥14.9B).
Debt to Equity History and Analysis
Debt Level: 4552's net debt to equity ratio (8.9%) is considered satisfactory.
Reducing Debt: 4552's debt to equity ratio has increased from 19% to 41.6% over the past 5 years.
Debt Coverage: 4552's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 4552 earns more interest than it pays, so coverage of interest payments is not a concern.